Search

Search Results

• PO:22:029 | Impact of mepolizumab on idiopathic hypereosinophilic syndromes: analysis of a monocentric retrospective cohort Jacopo Mora¹, Francesca Regola¹, Paola Toniati², Ilaria Cavazzana¹, Franco Franceschini¹. | ¹ASST Spedali Civili e Università degli Studi di Brescia, Brescia, Italy; ²ASST Spedali Civili di Brescia, Brescia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2053

  164

• PO:11:162 | DRESS syndrome: a case treated with mepolizumab Alessandro Belotti Masserini¹, Stefania Bertocchi¹, Eleonora Bruschi¹, Silvia Breda¹, Valeria Rossi¹, Elide Lupi¹, Tania Ubiali¹, Fabrizio Angeli¹, Massimiliano Limonta¹ | ¹ASST Papa Giovanni XXIII, Bergamo, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2152

  254
• 

  The place of ¹⁸F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report

  N. Belfeki, N. Louarn, I. Chouchane, A. Abbadi, S. Diamantis

  252-254

  18-01-2021

  https://doi.org/10.4081/reumatismo.2020.1353

  1224

  PDF: 692

• Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome

  N. Pugliese, M. Bruzzone, A. Della Rossa, C. Baldini, E. Catarsi, A. Tavoni, A. d'Ascanio, S. Bombardieri

  120-124

  https://doi.org/10.4081/reumatismo.2008.120

  1373

  PDF: 1887

• S02:5 | Combined anti-IL-5/IL-5r and dupilumab therapy in eosinophilic granulomatosis with polyangiitis: a European retrospective study Miriam Guerini¹, Pavel Novikov², Roberto Padoan³, Georgina Espigol Frigolé⁴, Jan Willem Cohen Tervaert⁵, Vincent Grobost⁶, Laurent Guilleminault⁷, Jan Walter Schroeder⁸, Bernhard Hellmich⁹, Joana Martins Martinho¹⁰, Camillo Ribi¹¹, Matthieu Groh¹², Benjamin Terrier¹³. | ¹IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy; ²Sechenov University, Moscow, Russia; ³University of Padova, Padova, Italy; ⁴Hospital Clinic, University of Barcelona, Barcelona, Spain; ⁵University of Alberta, Edmonton, Canada; ⁶CHU Estaing Clermont-Ferrand France; ⁷Toulouse University Toulouse France; ⁸ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; ⁹Medius Kliniken Kirchheim-Teck Germany; ¹⁰ULS Santa Maria, Lisbon, Portugal; ¹¹Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; ¹²Hopital Foch, Suresnes, France; ¹³Service de Medecine interne, Hopital Cochin, AP-HP, Paris, France.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2101

  276